|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 224.53 USD | -0.17% |
|
-2.97% | +14.46% |
| Capitalization | 38.3B 32.85B 30.72B 28.69B 53.42B 3,441B 57.86B 360B 139B 1,626B 144B 141B 5,928B | P/E ratio 2025 * |
31.7x | P/E ratio 2026 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise value | 51.67B 44.31B 41.44B 38.7B 72.05B 4,641B 78.05B 486B 188B 2,193B 194B 190B 7,996B | EV / Sales 2025 * |
3.19x | EV / Sales 2026 * | 2.99x |
| Free-Float |
67.55% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Iqvia Holdings Inc.
| 1 day | -0.17% | ||
| 1 week | -2.97% | ||
| Current month | -2.21% | ||
| 1 month | +6.62% | ||
| 3 months | +22.19% | ||
| 6 months | +52.08% | ||
| Current year | +14.46% |
| 1 week | 214.01 |  | 232.58 |
| 1 month | 206.72 | | 234.3 |
| Current year | 134.64 | | 234.3 |
| 1 year | 134.64 | | 234.3 |
| 3 years | 134.64 | | 261.73 |
| 5 years | 134.64 | | 285.61 |
| 10 years | 55.01 | | 285.61 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 64 | 2016-10-02 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 64 | 2020-07-31 |
Jeffrey Spaeder
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Leonard
BRD | Director/Board Member | 67 | 2015-02-04 |
John Connaughton
BRD | Director/Board Member | 59 | 2007-12-31 |
Ari Bousbib
CHM | Chairman | 64 | 2016-10-02 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 2.92% | 1 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.17% | -2.97% | +10.71% | +3.30% | 38.3B | |
| -0.69% | -0.62% | +5.12% | +9.74% | 48.03B | |
| -1.75% | -2.71% | +66.46% | +64.17% | 36.67B | |
| -0.38% | -1.40% | +8.96% | +19.18% | 27.13B | |
| -0.52% | -10.19% | +57.31% | +160.66% | 15.35B | |
| -0.07% | +1.16% | +62.65% | +207.40% | 15.17B | |
| -0.46% | +1.15% | -13.39% | -12.81% | 14.19B | |
| -1.09% | -1.14% | +31.63% | - | 13.58B | |
| +0.10% | -1.08% | +120.22% | +102.90% | 13.25B | |
| 0.00% | -0.68% | +59.21% | +66.35% | 12.74B | |
| Average | -0.56% | -1.78% | +40.89% | +68.99% | 23.44B | |
| Weighted average by Cap. | -0.64% | -1.72% | +33.07% | +50.30% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 16.19B 13.88B 12.98B 12.12B 22.58B 1,454B 24.45B 152B 58.77B 687B 60.76B 59.46B 2,505B | 17.06B 14.63B 13.68B 12.78B 23.79B 1,532B 25.77B 160B 61.93B 724B 64.03B 62.66B 2,640B |
| Net income | 1.23B 1.06B 990M 925M 1.72B 111B 1.87B 11.62B 4.48B 52.41B 4.63B 4.54B 191B | 1.45B 1.24B 1.16B 1.09B 2.02B 130B 2.19B 13.66B 5.27B 61.6B 5.45B 5.33B 225B |
| Net Debt | 13.37B 11.46B 10.72B 10.01B 18.64B 1,201B 20.19B 126B 48.52B 567B 50.16B 49.09B 2,068B | 12.68B 10.87B 10.17B 9.5B 17.68B 1,139B 19.15B 119B 46.03B 538B 47.58B 46.57B 1,962B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-04 | 224.92 $ | -1.02% | 3,298,872 |
| 25-12-03 | 227.24 $ | +0.71% | 1,225,130 |
| 25-12-02 | 225.63 $ | -1.24% | 1,566,064 |
| 25-12-01 | 228.47 $ | -0.67% | 1,266,879 |
| 25-11-28 | 230.01 $ | -0.77% | 471,421 |
Delayed Quote Nyse, December 04, 2025 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IQV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition